Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27144573 | 0.93 | SMN1; SMN2 (0.38) | ALDH1A1SMN1; SMN2FDPSTSHRLMNA | |
| SCHEMBL18124696 | 0.91 | ALDH1A1 (0.32) | ALDH1A1SMN1; SMN2FDPSTSHR | |
| SCHEMBL6398064 | 0.84 | DPP4 (0.32) | TSHR | |
| SCHEMBL228952 | 0.83 | ALDH1A1 (0.33) | ALDH1A1SMN1; SMN2FDPSTSHRLMNA | |
| SCHEMBL15501084 | 0.83 | ALDH1A1 (0.33) | ALDH1A1SMN1; SMN2FDPSTSHRLMNA | |
| SCHEMBL29780386 | 0.81 | ALDH1A1 (0.33) | ALDH1A1SMN1; SMN2FDPSTSHR | |
| SCHEMBL27145591 | 0.80 | ALDH1A1 (0.38) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| SCHEMBL406532 | 0.79 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL9236932 | 0.79 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL28438544 | 0.79 | TSHR (0.32) | FDPSTSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024204557-A1 | COMPOSITION, REACTIVE DILUENT, CURABLE COMPOSITION, AND METHOD FOR PRODUCING COMPOSITION | ＫＨネオケム株式会社 | 2024-10-03 | — | — | WO | disclosed |
| US-9550763-B2 | Heterocyclic ring and carbocyclic derivative | SHIONOGI & CO., LTD. (JP) | 2017-01-24 | — | — | US | disclosed |
| US-20160024072-A1 | Heterocyclic Ring and Carbocyclic Derivative | SHIONOGI & CO., LTD. (JP) | 2016-01-28 | — | — | US | disclosed |
| EP-1980576-B1 | PROPYLENE POLYMER, METHOD FOR PRODUCTION OF THE PROPYLENE POLYMER, PROPYLENE POLYMER COMPOSITION, AND MOLDED ARTICLE MANUFACTURED FROM THE COMPOSITION | JAPAN POLYPROPYLENE CORP (JP) | 2015-07-22 | — | — | EP | disclosed |
| US-8232358-B2 | Propylene-based polymer and production method therefor, propylene-based polymer composition and molded body made thereof | JAPAN POLYPROPYLENE CORPORATION (JP) | 2012-07-31 | — | — | US | disclosed |
| US-7858716-B2 | Polypropylene having high melt flow rate (MFR) value and excellent product qualities with high productivity and processibility; using a coordination catalyst including magnesium chloride, tetrabutyl titanate, dibutylphthalate;dimethylvinylsilane, diisopropyldimethoxysilane and anorganoaluminum compound | JAPAN POLYPROPYLENE CORPORATION (JP) | 2010-12-28 | — | — | US | disclosed |
| US-20100099811-A1 | PROPYLENE-BASED POLYMER AND PRODUCTION METHOD THEREFOR, PROPYLENE-BASED POLYMER COMPOSITION AND MOLDED BODY MADE THEREOF | JAPAN POLYPROPYLENE CORPORATION (JP) | 2010-04-22 | — | — | US | disclosed |
| US-20090259006-A1 | PROPYLENE POLYMER, METHOD FOR PRODUCTION OF THE PROPYLENE POLYMER, PROPYLENE POLYMER COMPOSITION, AND MOLDED ARTICLE MANUFACTURED FROM THE COMPOSITION | JAPAN POLYPROPYLENE CORPORATION (JP) | 2009-10-15 | — | — | US | disclosed |
| EP-1980576-A1 | PROPYLENE POLYMER, METHOD FOR PRODUCTION OF THE PROPYLENE POLYMER, PROPYLENE POLYMER COMPOSITION, AND MOLDED ARTICLE MANUFACTURED FROM THE COMPOSITION | Japan Polypropylene Corporation (JP) | 2008-10-15 | — | — | EP | disclosed |
| US-20050053630-A1 | Antiseptic/antifungal agent and endermic liniment composition which contains it | SHISEIDO COMPANY LTD. (JP) | 2005-03-10 | — | — | US | disclosed |
| EP-1201125-B1 | Antiseptic/antifungal agent and endermic liniment composition which contains it | SHISEIDO CO LTD (JP) | 2003-12-17 | — | — | EP | disclosed |
| US-6620418-B1 | Paraben-free antiseptic/antifungal composition which contains 3- methyl-3-methoxybutanol and 1,2-pentanediol in cosmetic form | SHISEIDO COMPANY, LTD. (JP) | 2003-09-16 | — | — | US | disclosed |
| EP-1040757-B1 | Antiseptic/antifungal agent and endermic liniment composition which contains it | SHISEIDO CO LTD (JP) | 2003-02-05 | — | — | EP | disclosed |
| EP-1201125-A1 | Antiseptic/antifungal agent and endermic liniment composition which contains it | SHISEIDO COMPANY LIMITED (JP) | 2002-05-02 | — | — | EP | disclosed |
| EP-1040757-A1 | Antiseptic/antifungal agent and endermic liniment composition which contains it | SHISEIDO COMPANY LIMITED (JP) | 2000-10-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160024072-A1 | Heterocyclic Ring and Carbocyclic Derivative | P2RX3, P2RX7, P2RX2 | ALDH1A1 2515/4885SMN1; SMN2 4746/4885FDPS 4552/4885 |
| US-20050053630-A1 | Antiseptic/antifungal agent and endermic liniment composition which contains it | DPM1, POLR1C, DERL1 | ALDH1A1 375/4885SMN1; SMN2 3532/4885FDPS 3779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.